Research study Program year 2021 Source: CMS Open Payments

AMG 510 Ph2 First Line Monotherapy NSCLC.

Research payments

$536,375

38 payments

Through program year 2021, $536,375 in research payments was reported against AMG 510 Ph2 First Line Monotherapy NSCLC., across 38 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$536,375	38

Breakdown

Who paid Research payments · program year 2021

Amgen Inc. $536,375 38 payments

Who received the money Research payments · program year 2021

Northwest Georgia Oncology Centers Pc Organisation paid for research $56,056 2 payments
Laura And Isaac Perlmutter Cancer Center At New York University Langone Organisation paid for research $40,495 2 payments
City Of Hope National Medical Ctr Teaching hospital · CA $37,072 1 payment
Texas Oncology - Flower Mound Organisation paid for research $37,016 1 payment
Texas Oncology- McKinney Organisation paid for research $37,013 1 payment
Texas Oncology - Plano East Organisation paid for research $37,012 1 payment
Texas Oncology-Dallas Presbyterian Hospital Organisation paid for research $37,012 1 payment
Texas Oncology - Medical City Dallas Organisation paid for research $37,012 1 payment
Arizona Oncology Associates Professional Corporation Organisation paid for research $37,012 1 payment
Texas Oncology-Denton Organisation paid for research $37,012 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.